Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
11,181,416
-
Total 13F shares
-
31,199,169
-
Share change
-
+6,212,432
-
Total reported value
-
$204,665,259
-
Price per share
-
$6.56
-
Number of holders
-
52
-
Value change
-
+$41,687,098
-
Number of buys
-
36
-
Number of sells
-
11
Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) as of Q2 2023
As of 30 Jun 2023,
Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) was held by
52 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,199,169 shares.
The largest 10 holders included
FMR LLC, Atlas Venture Life Science Advisors, LLC, ORBIMED ADVISORS LLC, BVF INC/IL, Omega Fund Management, LLC, CHI Advisors LLC, Artal Group S.A., Avoro Capital Advisors LLC, BlackRock Inc., and VANGUARD GROUP INC.
This page lists
52
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.